Poor water solubility is an increasingly common issue in pharmaceutical development. Approximately 40% of marketed drugs and as many as 90% of active pharmaceutical ingredients (APIs) in the discovery pipeline are poorly water-soluble. Dr Robert Lee at Particle Sciences explains why nanomilling is proving to offer drug developers great utility.